The elevation of longtime vaccine critics such as Malone and Levi to positions of influence in the ACIP is “unfortunate,” according to Robert Hopkins, M.D., an infectious disease physician and the ...
In the latest bunch of recommendations from the European Medicines | Sanofi, Novo Nordisk, UCB and others received positive ...
Earlier this month at the J.P. Morgan Healthcare Conference, Regeneron got its Eylea sales news out of the way. | For the ...
On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding ...
Quince Therapeutics’ novel method of delivering steroids in a patient’s own red blood cells has turned out to be a bust in ataxia-telangiectasia (A-T), a rare inherited disorder. | Quince Therapeutics ...
In this week’s episode of “The Top Line,” Fierce checks in with professional services juggernaut KPMG on the biopharma ...
The next stop in Vetter Pharma’s long-term growth strategy takes the German CDMO back to its home country, where it will devote approximately 480 million euros ($574.3 million) to the first constru | ...
AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results